Setting up companies for technological development of research results from public institutions is one of the most widely-used strategies for transfer of knowledge. As well as providing the system with new services and products, quality employment is generated and the production sector of regions is strengthened. For this reason the CIBER has an active policy to back companies promoted from its research groups and based on the technology developed at these.
If you are a researcher with ideas, get in touch with us; if you are an investor interested in getting to know about any of the initiatives under way or being prepared, why not contact us too.
EpiDisease supplies its clients with biomedical solutions and epigenetic diagnosis tools, characterises new epigenetic drugs and promotes translational research with the aim of improving people’s health and well-being.
Contact | Luzma García Piqueres
Head of technology transfer
Tfno: (+34) 91 171 81